2022
DOI: 10.1021/acs.analchem.1c04866
|View full text |Cite
|
Sign up to set email alerts
|

Framework Nucleic Acid-Based Spatial-Confinement Amplifier for miRNA Imaging in Living Cells

Abstract: Real-time in situ monitoring of miRNAs in living cells is often appealed to signal amplifiers to tackle their low abundance challenges. However, the poor kinetics of amplifiers and potential interferences from the complex intracellular environment hamper its widespread applications in vivo. Herein, we report a framework nucleic acid (FNA)-based nonenzymatic spatial-confinement amplifier for rapid and reliable intracellular miRNA imaging. The amplifier consists of a localized catalytic hairpin assembly (L-CHA) … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
20
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 42 publications
(20 citation statements)
references
References 45 publications
0
20
0
Order By: Relevance
“…MicroRNAs (miRNAs) are a series of small regulatory RNAs whose abnormal expression is associated with a variety of malignancies, so they have been suggested as a diagnostic method. However, miRNAs are not only aberrantly expressed in tumor cells but also in some cells in the stage of DNA damage, such as those after radiopharmaceutical treatment. Thus, researchers use only miRNA biomarkers to diagnose cellular disease types that may risk a false discovery rate result in overmedicalization. Therefore, it remains a huge challenge in tumor diagnosis and prognosis to distinguish tumor cells from DNA-damaged cells. Medical studies have shown that tumor cells witnessed the anomalous expression of mature microRNA (miRNA) and the normal expression of precursor microRNA (Pre-miRNA), while both were expressed abnormally in DNA-damaged cells. Accordingly, when both Pre-miRNA and miRNA can be simultaneously and accurately detected, it will be possible to distinguish tumor cells from DNA-damaged cells.…”
Section: Introductionmentioning
confidence: 99%
“…MicroRNAs (miRNAs) are a series of small regulatory RNAs whose abnormal expression is associated with a variety of malignancies, so they have been suggested as a diagnostic method. However, miRNAs are not only aberrantly expressed in tumor cells but also in some cells in the stage of DNA damage, such as those after radiopharmaceutical treatment. Thus, researchers use only miRNA biomarkers to diagnose cellular disease types that may risk a false discovery rate result in overmedicalization. Therefore, it remains a huge challenge in tumor diagnosis and prognosis to distinguish tumor cells from DNA-damaged cells. Medical studies have shown that tumor cells witnessed the anomalous expression of mature microRNA (miRNA) and the normal expression of precursor microRNA (Pre-miRNA), while both were expressed abnormally in DNA-damaged cells. Accordingly, when both Pre-miRNA and miRNA can be simultaneously and accurately detected, it will be possible to distinguish tumor cells from DNA-damaged cells.…”
Section: Introductionmentioning
confidence: 99%
“…Effective and sensitive detection of cancer-associated miRNAs is strongly needed in cancer diagnosis and related biological studies. Compared to other imaging methods which need preprocessing to extract miRNA from cell lysates, 58 DDNs allow in situ bioimaging of miRNA expression in living cells with better cell specicity and temporal accuracy. able to measure survivin mRNA, which is highly associated with malignant tumors, in live cancer cells with accuracy and sensitivity, but also can track survivin mRNA dynamically.…”
Section: Bioimagingmentioning
confidence: 99%
“…Effective and sensitive detection of cancer-associated miRNAs is strongly needed in cancer diagnosis and related biological studies. Compared to other imaging methods which need pre-processing to extract miRNA from cell lysates, 58 DDNs allow in situ bioimaging of miRNA expression in living cells with better cell specificity and temporal accuracy.…”
Section: Biomedical Applications Of Dynamic Dna Nanostructuresmentioning
confidence: 99%
“…Nevertheless, traditional CHA reactions relied on random collisions of reactants in a homogeneous solution with low collision efficiency and long reaction time, resulting in a low reaction rate and nonspecic background leakage, which limit further exploration and application of CHA. [30][31][32][33] Thus, how to improve the CHA reaction kinetics is the direction of our continuous efforts. For the past few years, tetrahedral DNA nanostructures (TDNs), as the classical frame nucleic acid, have attracted great attention [33][34][35][36] owing to their pre-engineered sizes, structural stability, excellent biocompatibility and cell permeability.…”
Section: Introductionmentioning
confidence: 99%